These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25555173)
21. A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis. Chen M; Gong L; Sun X; Gu Y; He X; Qu J; Wang L; Zhang M; Zhong X Curr Med Res Opin; 2012 Mar; 28(3):385-94. PubMed ID: 22256909 [TBL] [Abstract][Full Text] [Related]
22. Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot study. Ong NH; Purcell TL; Roch-Levecq AC; Wang D; Isidro MA; Bottos KM; Heichel CW; Schanzlin DJ Cornea; 2013 Jun; 32(6):761-5. PubMed ID: 23132445 [TBL] [Abstract][Full Text] [Related]
23. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure. Sheppard JD; Comstock TL; Cavet ME Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315 [TBL] [Abstract][Full Text] [Related]
24. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. Am J Ophthalmol; 1999 May; 127(5):537-44. PubMed ID: 10334346 [TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of Fluorometholone versus Loteprednol eye drops after photorefractive keratectomy: A triple-blinded randomized controlled trial. Razmjoo H; Mikaniki M; Peyman A; Mikaniki E; Abounoori M; Pourazizi M Eur J Ophthalmol; 2023 Jan; 33(1):595-601. PubMed ID: 35656757 [TBL] [Abstract][Full Text] [Related]
26. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. Lane SS; Holland EJ J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255 [TBL] [Abstract][Full Text] [Related]
27. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone? Koçluk Y; Sukgen EA; Cevher S; Mat E Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587 [TBL] [Abstract][Full Text] [Related]
28. The effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameter. Aras C; Ozdamar A; Aktunç R; Erçikan C Ophthalmic Surg Lasers; 1998 Aug; 29(8):621-7. PubMed ID: 9715485 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy. Shin JH; Lee HB; Park HY Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276 [TBL] [Abstract][Full Text] [Related]
30. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group. Dell SJ; Shulman DG; Lowry GM; Howes J Am J Ophthalmol; 1997 Jun; 123(6):791-7. PubMed ID: 9535623 [TBL] [Abstract][Full Text] [Related]
31. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Amon M; Busin M Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery. Rajpal RK; Roel L; Siou-Mermet R; Erb T J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817 [TBL] [Abstract][Full Text] [Related]
33. Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery. Shokoohi-Rad S; Daneshvar R; Jafarian-Shahri M; Rajaee P J Curr Ophthalmol; 2018 Jun; 30(2):130-135. PubMed ID: 29988925 [TBL] [Abstract][Full Text] [Related]
34. Factors that influence intraocular pressure changes after myopic and hyperopic LASIK and photorefractive keratectomy: a large population study. Schallhorn JM; Schallhorn SC; Ou Y Ophthalmology; 2015 Mar; 122(3):471-9. PubMed ID: 25444636 [TBL] [Abstract][Full Text] [Related]
35. The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. Burka JM; Bower KS; Vanroekel RC; Stutzman RD; Kuzmowych CP; Howard RS Am J Ophthalmol; 2005 Jul; 140(1):83-7. PubMed ID: 15953577 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Loteprednol with Fluorometholone after Myopic Photorefractive Keratectomy. Karimian F; Faramarzi A; Fekri S; Mohammad-Rabie H; Najdi D; Doozandeh A; Delfaza-Baher S; Yaseri M J Ophthalmic Vis Res; 2017; 12(1):11-16. PubMed ID: 28299001 [TBL] [Abstract][Full Text] [Related]
37. Pain, wound healing and refractive comparison of mechanical and transepithelial debridement in photorefractive keratectomy for myopia: results of 1 year follow-up. Celik U; Bozkurt E; Celik B; Demirok A; Yilmaz OF Cont Lens Anterior Eye; 2014 Dec; 37(6):420-6. PubMed ID: 25081522 [TBL] [Abstract][Full Text] [Related]
38. [Effects of amniotic extraction on epithelial wound healing and stromal remodelling after excimer laser keratectomy in rabbit cornea]. Xiao Q; Chen Y; Du J; Wang H; Li W; Liu Z Zhonghua Yan Ke Za Zhi; 2014 Jan; 50(1):42-50. PubMed ID: 24709133 [TBL] [Abstract][Full Text] [Related]
39. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. Asbell P; Howes J CLAO J; 1997 Jan; 23(1):31-6. PubMed ID: 9001768 [TBL] [Abstract][Full Text] [Related]
40. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial. Caldwell M; Reilly C J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]